• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

影响中国精神分裂症患者及照料者抗精神病药物治疗偏好的因素:一项离散选择实验

Factors Influencing Patient and Caregiver Preferences for Antipsychotic Treatment of Schizophrenia in China: A Discrete Choice Experiment.

作者信息

Zhang Weibo, He Siyuan, Wilson Liam, Foix-Colonier Astrid, Pacou Maud, Zhu Youwei, Zhu Yi, Xue Lili, Wang Yanfeng, Li Junmei, Liu Yanli, Cai Jun

机构信息

Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.

Mental Health Branch, China Hospital Development Institute, Shanghai Jiao Tong University, Shanghai, People's Republic of China.

出版信息

Patient Prefer Adherence. 2023 Jun 13;17:1421-1430. doi: 10.2147/PPA.S403252. eCollection 2023.

DOI:10.2147/PPA.S403252
PMID:37334189
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10276608/
Abstract

PURPOSE

This study aimed to quantify the preferences of Chinese patients with schizophrenia and their caregivers for antipsychotic treatment.

PATIENTS AND METHODS

Patients with schizophrenia (aged 18-35) and their caregivers were recruited via six outpatient mental health clinics in Shanghai, People's Republic of China. In a discrete choice experiment (DCE), participants chose between two hypothetical treatment scenarios that varied regarding the type of treatment, rate of hospitalization, severity of positive symptoms, treatment cost and rates of improvement in daily and social functioning. Data for each group were analyzed using the modelling approach that yielded the lower deviance information criterion. The relative importance score (RIS) for each treatment attribute was also determined.

RESULTS

A total of 162 patients and 167 caregivers participated. Frequency of hospital admission was the most important treatment attribute for patients (average scaled RIS=27%), followed by mode and frequency of treatment administration (24%). Improvement in ability to carry out daily activities (8%) and improvement in social functioning (8%) were least important. Patients in full-time employment placed more importance on the frequency of hospital admission than unemployed patients (p<0.01). Frequency of hospital admission was also the most important attribute for caregivers (RIS=33%), followed by improvement in positive symptoms (20%), while improvement in daily activities (7%) was the least important.

CONCLUSION

Patients with Schizophrenia in China prefer treatments that help reduce the number of times they are admitted to hospital, as do their caregivers. These results may bring insight for physicians and health authorities in China regarding the treatment characteristics that patients value the most.

摘要

目的

本研究旨在量化中国精神分裂症患者及其照料者对抗精神病药物治疗的偏好。

患者与方法

通过中华人民共和国上海的六家门诊心理健康诊所招募了年龄在18 - 35岁之间的精神分裂症患者及其照料者。在一项离散选择实验(DCE)中,参与者在两种假设的治疗方案之间进行选择,这两种方案在治疗类型、住院率、阳性症状严重程度、治疗成本以及日常和社会功能改善率等方面存在差异。使用产生较低偏差信息准则的建模方法对每组数据进行分析。还确定了每个治疗属性的相对重要性得分(RIS)。

结果

共有162名患者和167名照料者参与。住院频率是患者最重要的治疗属性(平均标化RIS = 27%),其次是治疗给药方式和频率(24%)。日常活动能力的改善(8%)和社会功能的改善(8%)最不重要。全职工作的患者比失业患者更重视住院频率(p<0.01)。住院频率也是照料者最重要的属性(RIS = 33%),其次是阳性症状的改善(20%),而日常活动的改善(7%)最不重要。

结论

中国的精神分裂症患者及其照料者都更喜欢有助于减少住院次数的治疗方法。这些结果可能为中国的医生和卫生当局提供有关患者最看重的治疗特征的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20ef/10276608/908e30b2f209/PPA-17-1421-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20ef/10276608/932bd2c0256f/PPA-17-1421-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20ef/10276608/908e30b2f209/PPA-17-1421-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20ef/10276608/932bd2c0256f/PPA-17-1421-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20ef/10276608/908e30b2f209/PPA-17-1421-g0002.jpg

相似文献

1
Factors Influencing Patient and Caregiver Preferences for Antipsychotic Treatment of Schizophrenia in China: A Discrete Choice Experiment.影响中国精神分裂症患者及照料者抗精神病药物治疗偏好的因素:一项离散选择实验
Patient Prefer Adherence. 2023 Jun 13;17:1421-1430. doi: 10.2147/PPA.S403252. eCollection 2023.
2
Letter to the Editor: Rethinking The Cost Of Antipsychotic Treatment: The Average Cost Of The Drugs Used In Turkey In 2020.给编辑的信:重新思考抗精神病药物治疗的成本:2020 年土耳其使用的药物的平均成本。
Turk Psikiyatri Derg. 2022 Summer;33(2):146-148. doi: 10.5080/u26315.
3
The personal, societal, and economic burden of schizophrenia in the People's Republic of China: implications for antipsychotic therapy.中华人民共和国精神分裂症的个人、社会和经济负担:对抗精神病药物治疗的启示。
Clinicoecon Outcomes Res. 2013 Aug 14;5:407-18. doi: 10.2147/CEOR.S44325. eCollection 2013.
4
Patient and caregiver preferences for haemophilia A treatments: A discrete choice experiment.患者和照护者对血友病 A 治疗药物的偏好:一项离散选择实验。
Haemophilia. 2020 Nov;26(6):e291-e299. doi: 10.1111/hae.14137. Epub 2020 Sep 16.
5
Patients' Preferences Related to Benefits, Risks, and Formulations of Schizophrenia Treatment.患者对精神分裂症治疗的益处、风险和制剂的偏好。
Psychiatr Serv. 2015 Jul;66(7):719-26. doi: 10.1176/appi.ps.201400188. Epub 2015 Mar 16.
6
Patient and Caregiver Treatment Preferences in Type 2 and Non-ambulatory Type 3 Spinal Muscular Atrophy: A Discrete Choice Experiment Survey in Five European Countries.2 型和非卧床 3 型脊髓性肌萎缩症患者和照护者的治疗偏好:在五个欧洲国家进行的离散选择实验调查。
Pharmacoeconomics. 2022 Apr;40(Suppl 1):103-115. doi: 10.1007/s40273-021-01118-2. Epub 2021 Dec 13.
7
Patient and Caregiver Preferences for Hemophilia A Treatment in Taiwan: A Discrete Choice Experiment.台湾地区血友病A治疗中患者及照护者的偏好:一项离散选择实验
Value Health Reg Issues. 2025 Jan;45:101035. doi: 10.1016/j.vhri.2024.101035. Epub 2024 Aug 27.
8
Patient preferences for topical psoriasis treatments: a discrete choice experiment.银屑病局部治疗的患者偏好:一项离散选择实验。
J Dermatolog Treat. 2022 Aug;33(5):2595-2604. doi: 10.1080/09546634.2022.2059052. Epub 2022 Apr 4.
9
Drivers of Patient and Caregiver Preferences for Growth Hormone Deficiency Treatments in France: A Discrete Choice Experiment.法国生长激素缺乏症治疗中患者及照料者偏好的驱动因素:一项离散选择实验
Horm Res Paediatr. 2025;98(1):13-24. doi: 10.1159/000534974. Epub 2023 Nov 29.
10
Patients' Preferences for Artificial Intelligence Applications Versus Clinicians in Disease Diagnosis During the SARS-CoV-2 Pandemic in China: Discrete Choice Experiment.中国 SARS-CoV-2 大流行期间,患者对人工智能应用与临床医生在疾病诊断中的偏好:离散选择实验。
J Med Internet Res. 2021 Feb 23;23(2):e22841. doi: 10.2196/22841.

引用本文的文献

1
The Evolving Landscape of Discrete Choice Experiments in Health Economics: A Systematic Review.健康经济学中离散选择实验的发展态势:一项系统综述
Pharmacoeconomics. 2025 May 21. doi: 10.1007/s40273-025-01495-y.

本文引用的文献

1
Patients' Preference for Long-Acting Injectable versus Oral Antipsychotics in Schizophrenia: Results from the Patient-Reported Medication Preference Questionnaire.精神分裂症患者对长效注射用抗精神病药物与口服抗精神病药物的偏好:患者报告的药物偏好问卷结果
Patient Prefer Adherence. 2020 Jul 2;14:1093-1102. doi: 10.2147/PPA.S251812. eCollection 2020.
2
Real-world effectiveness of long-acting injections for reducing recurrent hospitalizations in patients with schizophrenia.长效注射剂对降低精神分裂症患者再次住院率的真实世界有效性。
Ann Gen Psychiatry. 2020 Jan 14;19:1. doi: 10.1186/s12991-019-0254-2. eCollection 2020.
3
Time to Rehospitalization in Patients With Schizophrenia Receiving Long-Acting Injectable Antipsychotics or Oral Antipsychotics.
长效注射抗精神病药或口服抗精神病药治疗的精神分裂症患者再入院时间。
Int J Neuropsychopharmacol. 2019 Sep 1;22(9):541-547. doi: 10.1093/ijnp/pyz035.
4
Patient preferences concerning the efficacy and side-effect profile of schizophrenia medications: a survey of patients living with schizophrenia.患者对精神分裂症药物疗效和副作用特征的偏好:一项对精神分裂症患者的调查。
BMC Psychiatry. 2018 Sep 12;18(1):292. doi: 10.1186/s12888-018-1856-y.
5
Quantifying the treatment goals of people recently diagnosed with schizophrenia using best-worst scaling.运用最佳-最差标度法量化近期被诊断为精神分裂症患者的治疗目标。
Patient Prefer Adherence. 2018 Jan 4;12:63-70. doi: 10.2147/PPA.S152870. eCollection 2018.
6
Characterizing outcome preferences in patients with psychotic disorders: a discrete choice conjoint experiment.描述精神障碍患者的结局偏好:一项离散选择联合实验
Schizophr Res. 2017 Jul;185:107-113. doi: 10.1016/j.schres.2016.12.018. Epub 2016 Dec 27.
7
Physician and patient benefit-risk preferences from two randomized long-acting injectable antipsychotic trials.两项随机长效注射用抗精神病药物试验中医生和患者的获益-风险偏好
Patient Prefer Adherence. 2016 Oct 21;10:2127-2139. doi: 10.2147/PPA.S114172. eCollection 2016.
8
Prevalence of schizophrenia in China between 1990 and 2010.1990年至2010年间中国精神分裂症的患病率。
J Glob Health. 2015 Jun;5(1):010410. doi: 10.7189/jogh.05.010410.
9
High relapse rate and poor medication adherence in the Chinese population with schizophrenia: results from an observational survey in the People's Republic of China.中国精神分裂症患者的高复发率和低药物依从性:来自中华人民共和国的一项观察性调查结果。
Neuropsychiatr Dis Treat. 2015 May 8;11:1161-7. doi: 10.2147/NDT.S72367. eCollection 2015.
10
Patients' Preferences Related to Benefits, Risks, and Formulations of Schizophrenia Treatment.患者对精神分裂症治疗的益处、风险和制剂的偏好。
Psychiatr Serv. 2015 Jul;66(7):719-26. doi: 10.1176/appi.ps.201400188. Epub 2015 Mar 16.